Some information on this website may be viewed only by healthcare professionals.
If you would like to enter this section then please register as a healthcare professional.
Dr Falk Pharma UK Ltd Privacy Policy can be found here.
Please note that our privacy policy has recently been updated. Click here to review the policy.
Leading the way in gastroenterology and metabolic disease
Access to expert education, events and resources for gastro and metabolic diseases is limited. It’s challenging to stay on top of the continual advancements in this field so we’ve developed THE DR FALK WAY
Innovative and reliable treatments for gastroenterology and metabolic diseases
Inflammatory Bowel Disease (IBD) is a term mainly used to describe three conditions namely Ulcerative Colitis, Crohn’s Disease and Microscopic Colitis. These are chronic conditions that involve inflammation of the gastrointestinal tract. MC is the most recently recognised condition to be classed as IBD and it has become increasingly recognised over the last few years as a common condition.
The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis, Autoimmune Hepatitis and Primary Sclerosing Cholangitis. These diseases have chronic clinical courses and if left untreated can lead to serious consequences such as liver cirrhosis and death.
EoE is a chronic and progressive inflammatory disease which affects the lining of the oesophagus. Originally referred to as asthma of the oesophagus, EoE is thought to be triggered by an allergic response, usually to food but possibly also to environmental or other factors.
We believe that by creating a strong community. Together we know more, together we do more.
Available on your computer, tablet and mobile
We are thrilled to announce that Cork will shortly host a combined Inflammatory Bowel Disease and Hepatology Forum on Friday, 27th Sep 2024, at the Metropole Hotel in Cork City. We are truly privileged to..
It is our privilege and honour to invite you cordially to the Symposium “Immuno-Mediated Diseases of the GI Tract: Where Do We Stand?” in Florence (Italy). While the prevalence of immuno-mediated diseases of the gastrointestinal..
